Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32,901 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China.
Liao EY, Zhang ZL, Xia WB, Lin H, Cheng Q, Wang L, Hao YQ, Chen DC, Tang H, Peng YD, You L, He L, Hu ZH, Song CL, Wei F, Wang J, Zhang L. Liao EY, et al. Among authors: lin h. Medicine (Baltimore). 2018 Aug;97(31):e11694. doi: 10.1097/MD.0000000000011694. Medicine (Baltimore). 2018. PMID: 30075569 Free PMC article. Clinical Trial.
The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data.
Gu JM, Wang L, Lin H, Chen DC, Tang H, Jin XL, Xia WB, Hu YQ, Fu WZ, He JW, Zhang H, Wang C, Yue H, Hu WW, Liu YJ, Zhang ZL. Gu JM, et al. Among authors: lin h. Acta Pharmacol Sin. 2015 Jul;36(7):841-6. doi: 10.1038/aps.2015.30. Epub 2015 Jun 8. Acta Pharmacol Sin. 2015. PMID: 26051110 Free PMC article. Clinical Trial.
Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal.
Liao EY, Zhang ZL, Xia WB, Lin H, Cheng Q, Wang L, Hao YQ, Chen DC, Tang H, Peng YD, You L, He L, Hu ZH, Song CL, Wei F, Wang J, Zhang L. Liao EY, et al. Among authors: lin h. BMC Musculoskelet Disord. 2018 Jul 3;19(1):210. doi: 10.1186/s12891-018-2090-y. BMC Musculoskelet Disord. 2018. PMID: 29970059 Free PMC article. Clinical Trial.
East meets West: current practices and policies in the management of musculoskeletal aging.
Xia W, Cooper C, Li M, Xu L, Rizzoli R, Zhu M, Lin H, Beard J, Ding Y, Yu W, Cavalier E, Zhang Z, Kanis JA, Cheng Q, Wang Q, Reginster JY. Xia W, et al. Among authors: lin h. Aging Clin Exp Res. 2019 Oct;31(10):1351-1373. doi: 10.1007/s40520-019-01282-8. Epub 2019 Aug 2. Aging Clin Exp Res. 2019. PMID: 31376119 Free PMC article. Review.
Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study.
Wang L, Yu W, Yin X, Cui L, Tang S, Jiang N, Cui L, Zhao N, Lin Q, Chen L, Lin H, Jin X, Dong Z, Ren Z, Hou Z, Zhang Y, Zhong J, Cai S, Liu Y, Meng R, Deng Y, Ding X, Ma J, Xie Z, Shen L, Wu W, Zhang M, Ying Q, Zeng Y, Dong J, Cummings SR, Li Z, Xia W. Wang L, et al. Among authors: lin q, lin h. JAMA Netw Open. 2021 Aug 2;4(8):e2121106. doi: 10.1001/jamanetworkopen.2021.21106. JAMA Netw Open. 2021. PMID: 34398202 Free PMC article.
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk.
Zhang H, Gu JM, Chao AJ, Cheng Q, Teng DH, Yu JM, Wang BW, Huo YN, Mao L, Zhang Q, Yang H, Yan SG, Zhang KQ, Zhao XL, Lin H, Pei Y, Yuan Z, Dai RC, He L, Chen L, Su YF, Deng ZL, You L, Ban B, Zhu M, Cao YL, Zhu YK, Li ZJ, Zhang Z, Yi CQ, Lu YB, Wang G, Han CC, Wang ZJ, Li XX, Zhang ZL. Zhang H, et al. Among authors: lin h. Acta Pharmacol Sin. 2023 Feb;44(2):446-453. doi: 10.1038/s41401-022-00954-y. Epub 2022 Jul 27. Acta Pharmacol Sin. 2023. PMID: 35896694 Free PMC article. Clinical Trial.
Jintiange combined with alfacalcidol improves muscle strength and balance in primary osteoporosis: A randomized, double-blind, double-dummy, positive-controlled, multicenter clinical trial.
Liang H, Wang O, Cheng Z, Xia P, Wang L, Shen J, Kong X, Zeng Y, Chao A, Yan L, Lin H, Sun H, Cheng Q, Zhu M, Hu Z, Zhang Z, Tang H, Xia W. Liang H, et al. Among authors: lin h. J Orthop Translat. 2022 Aug 24;35:53-61. doi: 10.1016/j.jot.2022.05.002. eCollection 2022 Jul. J Orthop Translat. 2022. PMID: 36090002 Free PMC article.
32,901 results
You have reached the last available page of results. Please see the User Guide for more information.